Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia

作者: Abdulaziz AlObaid , Ismail A Al-Badawi , Hanan Al-Kadri , Kusuma Gopala , Walid Kandeil

DOI: 10.1186/S12879-014-0643-8

关键词:

摘要: Cervical cancer (CC) is caused by persistent infection with high-risk (HR) human papillomavirus (HPV) types. In Saudi Arabia which has a population of 6.5 million women over the age 15 years, approximately 152 new cases CC are diagnosed and 55 die from disease annually. Nevertheless current epidemiological data for HPV in this limited. This study evaluated prevalence type distribution documented awareness health-related behavior among non-Saudi attending routine examination. was an observational, cross-sectional conducted between April 2010 December 2011 at three hospitals Arabia. samples aged ≥15 years, who were gynecological examinations collected tested HPV-DNA polymerase chain reaction typed using SPF10 DEIA/LiPA25 system. Two questionnaires on completed. A total 417 women, mean (standard deviation) 41.9 (±10.4) years, included final analysis, whom 77% (321/417) nationals. detected 9.8% (41/417, 95% confidence interval [CI]: 7.1-13.1). The any HR-HPV was: 25–34 years: 3.0%; 35–44 4.5%; 45–54 3.2%; >55 years: 10.9%. most prevalent HR-HPV-types were: HPV-68/73 (5 cases); HPV-18 (4 HPV-16 (3 cases). low risk (LR) types HPV-6 HPV-42, HPV-53 HPV-54 (2 each). higher nationals vs. (16.7% 7.8%, P = 0.0234). No statistically significant factors identified: 32.2% (101/314) aware 89.9% (285/317) showed interest vaccination. overall Arabia, but 55 years, as well These provide reference public health authorities may also help determining future policies prevention CC. NCT01213459

参考文章(31)
Cecilia M Roteli-Martins, Paulo Naud, Paola De Borba, Julio C Teixeira, Newton S De Carvalho, Toufik Zahaf, Nervo Sanchez, Brecht Geeraerts, Dominique Descamps, None, Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine : up to 8.4 years of follow-up Human Vaccines & Immunotherapeutics. ,vol. 8, pp. 390- 397 ,(2012) , 10.4161/HV.18865
Mitzie-Ann Davis, Ronald H. Gray, Mary K. Grabowski, David Serwadda, Godfrey Kigozi, Patti E. Gravitt, Fred Nalugoda, Stephen Watya, Maria J. Wawer, Thomas C. Quinn, Aaron A.R. Tobian, Male circumcision decreases high-risk human papillomavirus viral load in female partners: A randomized trial in Rakai, Uganda International Journal of Cancer. ,vol. 133, pp. 1247- 1252 ,(2013) , 10.1002/IJC.28100
Nabeel Salem Bondagji, Faten Salah Gazzaz, Khalid Sait, Layla Abdullah, Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia. Annals of Saudi Medicine. ,vol. 33, pp. 13- 17 ,(2013) , 10.5144/0256-4947.2013.13
Dominique Descamps, Karin Hardt, Bart Spiessens, Patricia Izurieta, Thomas Verstraeten, Thomas Breuer, Gary Dubin, Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Human Vaccines. ,vol. 5, pp. 332- 340 ,(2009) , 10.4161/HV.5.5.7211
X Castellsagué, N Muñoz, P Pitisuttithum, D Ferris, J Monsonego, K Ault, J Luna, E Myers, S Mallary, O M Bautista, J Bryan, S Vuocolo, R M Haupt, A Saah, End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age British Journal of Cancer. ,vol. 105, pp. 28- 37 ,(2011) , 10.1038/BJC.2011.185
Mark H. Einstein, Mira Baron, Myron J. Levin, Archana Chatterjee, Bradley Fox, Sofia Scholar, Jeffrey Rosen, Nahida Chakhtoura, Dorothée Meric, Francis J. Dessy, Sanjoy Kumar Datta, Dominique Descamps, Gary Dubin, Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years. Human Vaccines. ,vol. 7, pp. 1343- 1358 ,(2011) , 10.4161/HV.7.12.18281
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Jan M. M. Walboomers, Marcel V. Jacobs, M. Michele Manos, F. Xavier Bosch, J. Alain Kummer, Keerti V. Shah, Peter J. F. Snijders, Julian Peto, Chris J. L. M. Meijer, Nubia Mu�oz, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. ,vol. 189, pp. 12- 19 ,(1999) , 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Ismail A. Al-Badawi, Abdulrahman Al-Suwaine, Murad Al-Aker, Lina Asaad, Alwaleed Alaidan, Asma Tulbah, Marie Fe Bohol, Adnan R. Munkarah, Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. International Journal of Gynecological Cancer. ,vol. 21, pp. 907- 910 ,(2011) , 10.1097/IGC.0B013E318214219F